ESPEN guidelines for nutrition in liver disease and transplantation. (Q53000549)

10 May 2018

title

ESPEN guidelines for nutrition in liver disease and transplantation. (English)

1 reference

10 May 2018

1 reference

2

1 reference

10 May 2018

author name string

M Plauth

1

1 reference

10 May 2018

J Kondrup

3

1 reference

10 May 2018

A Weimann

4

1 reference

10 May 2018

P Ferenci

5

1 reference

10 May 2018

M J Müller

6

1 reference

10 May 2018

ESPEN Consensus Group

7

1 reference

10 May 2018

publication date

1 April 1997

1 reference

10 May 2018

published in

Clinical Nutrition

1 reference

10 May 2018

volume

16

1 reference

10 May 2018

page(s)

43-55

1 reference

10 May 2018

issue

2

1 reference

10 May 2018

TREATMENT OF CIRRHOSIS OF THE LIVER BY A NUTRITIOUS DIET AND SUPPLEMENTS RICH IN VITAMIN B COMPLEX

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Protein-calorie malnutrition in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nature and quantity of fuels consumed in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Basal energy production rate and substrate use in stable cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Glucose and insulin metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Mechanism of insulin resistance associated with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Early postprandial energy expenditure and macronutrient use after a mixed meal in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Splanchnic and leg exchange of free fatty acids in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Metabolic responses to lipid infusions in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Disordered Energy and Protein Metabolism in Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Long-term oral refeeding of patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Accelerated improvement of alcoholic liver disease with enteral nutrition.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Energy metabolism in patients with acute and chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Ascites increases the resting energy expenditure in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

The unbearable lightness of being ... a cirrhotic

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Urinary creatinine excretion and lean body mass

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Whole-body and segmental bioelectrical-impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Are patients with liver cirrhosis hypermetabolic?

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Optimal nutritional indexes in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Pathogenesis and assessment of malnutrition in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Impact of nutritional support on the clinical outcome of the surgical patient

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Reduction of operative morbidity and mortality by combined preoperative and postoperative nutritional support

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Malnutrition and immuno-incompetence in patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nutritional issues in hepatobiliary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Aminoacid therapy of alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect of parenteral amino acid supplementation in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Body protein metabolism and plasma amino acids in cirrhosis of the liver. The effect of varying the branched chain amino acid content of intravenous amino acid solutions.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effects of branched-chain amino acids on nitrogen metabolism in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Short-term changes in energy metabolism after 1 month of a regular oral diet in severely malnourished cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA Cooperative Study Group #275

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

d-Alpha-tocopheryl polyethylene glycol-1000 succinate enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Use of growth hormone and insulin-like growth factor I in catabolism that is induced by negative energy balance

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effect of vegetable and animal protein diets in chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Overt hepatic encephalopathy precipitated by zinc deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Metabolic effects of enteral formula feeding in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Resting energy expenditure and nutritional state in patients with liver cirrhosis before and after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nutritional support after liver transplantation: a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Early enteral nutrition support in patients undergoing liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Tube jejunostomy in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Comparison of enteral feeding and total parenteral nutrition after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Excessive weight gain after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Perioperative nutrition: the rationale for nutritional support

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nutritional support for liver transplantation: identifying caloric and protein requirements.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Glucose metabolism in man: responses to intravenous glucose infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Central pontine myelinolysis after correction of chronic hyponatraemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Resting energy expenditure in patients with end-stage liver disease and in normal population.

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Are patients with chronic liver disease hypermetabolic?

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Energy metabolism in acute hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

The thermogenic and metabolic effects of food in liver cirrhosis: consequences on the storage of nutrients and the hormonal counterregulatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Effects of treadmill exercise on fuel metabolism in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Alcohol, liver, and nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Nutritional therapy in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Assessment of nutritional status and in vivo immune responses in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Tissue zinc status and drug elimination in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Selenium in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

Fat emulsions in parenteral nutrition after liver transplantation: The recovery of the allografts RES function and histological observations

1 reference

https://api.crossref.org/works/10.1016%2FS0261-5614%2897%2980022-2

7 January 2021

10.1016/S0261-5614(97)80022-2

Identifiers

DOI

1 reference

10 May 2018

PubMed ID

16844569

1 reference

10 May 2018